Hai Qian
China Pharmaceutical University(CN)Drug Discovery Laboratory (Norway)(NO)
Publications by Year
Research Areas
Diabetes Treatment and Management, Drug Transport and Resistance Mechanisms, Chemical Synthesis and Analysis, Pancreatic function and diabetes, Cancer therapeutics and mechanisms
Most-Cited Works
- → Interleukin‐23: as a drug target for autoimmune inflammatory diseases(2011)330 cited
- → pH-sensitive peptide hydrogel for glucose-responsive insulin delivery(2017)169 cited
- → Putting Fairness Principles into Practice(2019)113 cited
- → Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges(2017)93 cited
- → Performance of Doxorubicin-Conjugated Gold Nanoparticles: Regulation of Drug Location(2017)91 cited
- → Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development(2016)86 cited
- → Design, Synthesis, and Biological Activity of Novel Dicoumarol Glucagon-like Peptide 1 Conjugates